COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies.
Bhella S, Wilkin AM, Hueniken K, Vijenthira A, Sebag M, Wang P, Hicks LK, Hay AE, Assouline S, Fraser G, Balitsky A, Mangel J, Owen C, Reiman A, Sehn L, Sutherland H, Zhang T, Arnold C, Leite T, McCarthy E, Cooper C, Langlois MA, Arianne Buchan C; VIP Study Investigators.
Bhella S, et al. Among authors: vijenthira a.
Vaccine. 2024 Oct 24;42(24):126074. doi: 10.1016/j.vaccine.2024.06.041. Epub 2024 Jun 28.
Vaccine. 2024.
PMID: 38944577
Free article.